Novalis II General Partner BV
Ottergemsesteenweg-Zuid 808 Bus B511
9000 Gent
BE
Novalis II General Partner BV
Foundation date
21/08/2017
Sector
#InvestorSubsector
Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.
Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.
Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.
As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
New way of twisting fibers improves energy storage in wearable devices
4 hours ago
Read more
-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
1 day ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
Jobs
More jobs-
-
22/11/24
Flemish Brabant
ERC-funded postdoctoral position on engineering gut bacteria for live biotherapeutic applications
Permanent
VIB -
More info?
Ellen Telleir
Communication Coordinator